• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本肝癌发病率的时间变化:考虑死亡证明的不准确之处并改进诊断技术。

Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques.

作者信息

Sharp G B, Cologne J B, Fukuhara T, Itakura H, Yamamoto M, Tokuoka S

机构信息

Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.

出版信息

Int J Cancer. 2001 Sep 1;93(5):751-8. doi: 10.1002/ijc.1390.

DOI:10.1002/ijc.1390
PMID:11477591
Abstract

Primary liver cancer (PLC) rates have risen dramatically during the past few decades in some regions, particularly in Japan, where PLC is now the third major cause of cancer death. PLC is one of the most difficult tumors to diagnose correctly, because (i) the liver is a frequent site of cancer metastasis and (ii) death from PLC is often attributed to cirrhosis or chronic hepatitis. Also, because the disease is often rapidly fatal, a large proportion of liver cancer cases are identified based on death certificates alone without confirmation by clinical records. Thus, worldwide differences in published incidence rates for this disease reflect regional or national differences in both the accuracy of death certificates and the sensitivity of diagnostic methods. By comparing death certificate causes of death with those based on pathology review, we were able to adjust 1958--1994 incidence rates for a large Japanese cohort for these errors. Although the death certificate false-positive error rate declined, the false-negative error rate remained high throughout the study. The introduction of improved liver cancer diagnostic methods in Japan in the early 1980s was associated with a sharp increase in PLC incidence. We conclude that errors in death certificate causes of death and changes in liver cancer diagnostic techniques have had an important impact on the reported incidence of this disease. Taking these factors into account, rates of hepatocellular carcinoma rose between 2.4- and 4.3-fold in our Japanese cohort from 1960 to 1985, peaked about 1993 and declined thereafter. Incidence rates of cholangiocarcinoma remained stable through 1987.

摘要

在过去几十年中,某些地区的原发性肝癌(PLC)发病率急剧上升,尤其是在日本,如今PLC已成为癌症死亡的第三大主要原因。PLC是最难正确诊断的肿瘤之一,原因如下:(i)肝脏是癌症转移的常见部位;(ii)PLC导致的死亡常归因于肝硬化或慢性肝炎。此外,由于该疾病往往迅速致命,很大一部分肝癌病例仅根据死亡证明确诊,未经临床记录证实。因此,全球该疾病公布的发病率差异反映了死亡证明准确性和诊断方法敏感性在地区或国家层面的差异。通过比较死亡证明上的死因与病理检查确定的死因,我们能够对日本一个大型队列1958 - 1994年的发病率进行这些误差调整。尽管死亡证明的假阳性错误率有所下降,但在整个研究过程中,假阴性错误率仍然很高。20世纪80年代初日本引入改进的肝癌诊断方法后,PLC发病率急剧上升。我们得出结论,死亡证明死因的误差以及肝癌诊断技术的变化对该疾病报告的发病率产生了重要影响。考虑到这些因素,我们日本队列中肝细胞癌的发病率在1960年至1985年间上升了2.4至4.3倍,在1 about 1993年左右达到峰值,此后下降。胆管癌的发病率在1987年之前保持稳定。

相似文献

1
Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques.日本肝癌发病率的时间变化:考虑死亡证明的不准确之处并改进诊断技术。
Int J Cancer. 2001 Sep 1;93(5):751-8. doi: 10.1002/ijc.1390.
2
Rising incidence of primary liver cancer in Brunei Darussalam.文莱达鲁萨兰国原发性肝癌发病率上升。
Asian Pac J Cancer Prev. 2013;14(6):3473-7. doi: 10.7314/apjcp.2013.14.6.3473.
3
Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.日本丙型肝炎病毒相关肝硬化患者原发性肝内胆管细胞癌的发病率
Cancer. 2000 Jun 1;88(11):2471-7. doi: 10.1002/1097-0142(20000601)88:11<2471::aid-cncr7>3.0.co;2-t.
4
Misclassification of primary liver cancer in the Life Span Study of atomic bomb survivors.在原子弹幸存者寿命研究中对原发性肝癌的误诊。
Int J Cancer. 2020 Sep 1;147(5):1294-1299. doi: 10.1002/ijc.32887. Epub 2020 Feb 15.
5
The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.肝癌向癌症登记处的漏报和对数线性模型估计更准确的发病率。
Hepatology. 2017 Mar;65(3):885-892. doi: 10.1002/hep.28775. Epub 2016 Sep 30.
6
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].[肝细胞癌和胆管癌——不同的预后、发病机制及治疗]
Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195.
7
Influence of death certificate errors on cancer mortality trends.死亡证明错误对癌症死亡率趋势的影响。
J Natl Cancer Inst. 1993 Jul 7;85(13):1063-8. doi: 10.1093/jnci/85.13.1063.
8
Characteristics of hepatocellular carcinoma in Japan.日本肝细胞癌的特征。
Oncology. 2002;62 Suppl 1:5-7. doi: 10.1159/000048269.
9
Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.英格兰和威尔士原发性肝癌的发病率与死亡率:变化趋势及种族差异
World J Gastroenterol. 2014 Feb 14;20(6):1544-53. doi: 10.3748/wjg.v20.i6.1544.
10
Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.肝硬化患者患肝癌及其他类型癌症的风险:丹麦一项全国性队列研究
Hepatology. 1998 Oct;28(4):921-5. doi: 10.1002/hep.510280404.

引用本文的文献

1
Long-Term Trend of Liver Cancer Mortality in Serbia, 1991-2015: An Age-Period-Cohort and Joinpoint Regression Analysis.塞尔维亚1991 - 2015年肝癌死亡率的长期趋势:年龄-时期-队列及连接点回归分析
Healthcare (Basel). 2020 Aug 21;8(3):283. doi: 10.3390/healthcare8030283.
2
Misclassification of primary liver cancer in the Life Span Study of atomic bomb survivors.在原子弹幸存者寿命研究中对原发性肝癌的误诊。
Int J Cancer. 2020 Sep 1;147(5):1294-1299. doi: 10.1002/ijc.32887. Epub 2020 Feb 15.
3
Radiation and Risk of Liver, Biliary Tract, and Pancreatic Cancers among Atomic Bomb Survivors in Hiroshima and Nagasaki: 1958-2009.
广岛和长崎原子弹幸存者中辐射与肝、胆道和胰腺癌症风险:1958-2009 年。
Radiat Res. 2019 Sep;192(3):299-310. doi: 10.1667/RR15341.1. Epub 2019 Jul 10.
4
Liver cancer mortality trends in South Africa: 1999-2015.南非肝癌死亡率趋势:1999-2015 年。
BMC Cancer. 2018 Aug 7;18(1):798. doi: 10.1186/s12885-018-4695-9.
5
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.切除的肝细胞癌合并胆管癌的艾伦C型分类的临床和病理特征:与肝细胞癌和胆管细胞癌的比较研究
J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98. doi: 10.1016/j.gassur.2006.01.018.
6
[Gallbladder and bile duct carcinoma. Biology and pathology].[胆囊和胆管癌。生物学与病理学]
Internist (Berl). 2004 Jan;45(1):33-41. doi: 10.1007/s00108-003-1110-6.